2026. 06 | Nirsevimab as a key strategy to prevent respiratory syncytial virus among newborns and children: real-world evidence from Italy and Sicily. EuroMediterranean Biomedical Journal. 21, s1 (Nov. 2026). DOI:https://doi.org/10.3269/q1nt4g06.